InterVenn Enters into Collaboration with Agilent Technologies on Clinical Glycoproteomic Analysis

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–InterVenn, a San Francisco based biotechnology company innovating precision medicine and diagnostic products using next-generation mass spectrometry coupled to a proprietary artificial Intelligence/machine learning-based data processing engine, has announced a collaboration with Agilent Technologies, a leading provider of bio-analytical and scientific instrumentation. The signing of the collaboration took place on 7 […]